EyePoint Pharmaceuticals
EYPT
#5229
Rank
A$2.22 B
Marketcap
A$26.90
Share price
0.45%
Change (1 day)
94.50%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Cash on Hand

Cash on Hand as of September 2025 : A$0.30 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has A$0.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.59 B22.72%
2023-12-31A$0.48 B128.74%
2022-12-31A$0.21 B-27.2%
2021-12-31A$0.29 B399.64%
2020-12-31A$58.4 M84.08%
2019-12-31A$31.72 M
2018-06-30A$52.37 M137.98%
2017-06-30A$22 M-43.45%
2016-06-30A$38.92 M4.95%
2015-06-30A$37.08 M91.33%
2014-06-30A$19.38 M72.25%
2013-06-30A$11.25 M-20.9%
2012-06-30A$14.22 M-36.8%
2011-06-30A$22.51 M8.56%
2010-06-30A$20.73 M143.17%
2009-06-30A$8.52 M-47.75%
2008-06-30A$16.32 M417.59%
2007-06-30A$3.15 M-79.66%
2006-06-30A$15.5 M20.85%
2005-06-30A$12.83 M-59.32%
2004-06-30A$31.54 M2557.16%
2003-06-30A$1.18 M
2001-06-30A$3.21 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
A$3.34 M-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
A$0.19 M-99.94% Bahamas